Tandem Diabetes (TNDM) Tops Q4 EPS by 9c, Revenues Miss; Offers FY20 Revenue Guidance Above Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/15/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. ADYYF
10. DVLT

Go back to Tandem Diabetes (TNDM) Tops Q4 EPS by 9c, Revenues Miss; Offers FY20 Revenue Guidance Above Consensus

Tandem Diabetes Care (TNDM) PT Raised to $82 at Baird

February 21, 2020 8:16 AM EST

Baird analyst Jeff Johnson raised the price target on Tandem Diabetes Care (NASDAQ: TNDM) to $82.00 (from $75.00) while maintaining a Neutral rating.... More